慢性呼吸道疾病:使用量子粒子作为纳米异常剂
Neelam1, Shefali Mallik1, K M Neethu1
1Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Berhampur, Odisha, India.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
|October 29, 2025
概括
量子点 (QD) 为慢性呼吸系统疾病 (如COPD和喘) 提供先进的纳米诊断和纳米治疗解决方案. 它们独特的特性增强了早期检测和治疗,改善了患者的治疗结果.
科学领域:
- 纳米技术 纳米技术
- 呼吸系统医学 呼吸系统医学
- 诊断工具 诊断工具 诊断工具
- 治疗方法的治疗方法
背景情况:
- 慢性呼吸道疾病 (CRD) 是全球死亡和发病的主要原因.
- 有效的管理需要准确的诊断和及时的治疗.
- 纳米技术为CRD诊断和治疗提供了新的解决方案.
研究的目的:
- 审查量子点 (QD) 用于诊断和治疗慢性呼吸系统疾病的特性.
- 探索QDs在生物成像中的潜力,并作为传统光体的替代品.
- 讨论呼吸系统疾病纳米医学中QD应用的挑战和未来方向.
主要方法:
- 关于用于纳米诊断和纳米治疗的量子点 (QD) 的文献综述.
- 分析QD光物理特性,表面功能化和毒性.
- 讨论生物成像和针对呼吸道疾病的向药物输送中的QD应用.
主要成果:
- QDs具有独特的光物理特性,适用于敏感的生物传感和生物成像.
- 表面功能化允许针对呼吸道疾病提供治疗剂.
- QD显示出作为CRD有效的纳米隔离剂的潜力.
结论:
- 量子点代表了慢性呼吸道疾病的有前途的纳米激光平台.
- 需要进一步的研究来应对QD毒性和临床应用的清除等挑战.
- QD可以显著提升呼吸系统疾病的诊断和治疗.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Inhaled Medications
728
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
728
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K


